The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone.
Wardley, Andrew M Jayson, Gordon C Goldsmith, D J Venning, M C Ackrill, P Scarffe, J Howard
Wardley, Andrew M
Jayson, Gordon C
Goldsmith, D J
Venning, M C
Ackrill, P
Scarffe, J Howard
Citations
Altmetric:
Abstract
Three out of four patients with primary (light chain) amyloid nephrotic syndrome treated with vincristine, doxorubicin and dexamethasone (VAD) induction obtained a partial response and are alive in continuing remission at 4.1, 6.5 and 9.3 years. These preliminary results are of considerable interest and suggest that prospective evaluation of this regimen is warranted in patients with this condition.
Description
Date
1998-09
Publisher
Collections
Keywords
Type
Article
Citation
The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone. 1998, 78 (6):774-6 Br. J. Cancer